Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOPDAPT-3
jRCTs052200114Completed
- Sponsor
- Research Institute for Production Development
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of prasugrel, aspirin and clopidogrel in coronary arteriosclerosis, stable angina and myocardial infarction (MI) (2 arms), sponsored by Research Institute for Production Development. Primary endpoints: Major bleeding at 1 month and Cardiovascular composite at 1 month. Started Jan 2021; status: completed.
02
Drugs
prasugrelaspirinclopidogrel
03
Conditions
coronary arteriosclerosisstable anginamyocardial infarction (MI)
Beyond the preview
Go deeper on jRCTs052200114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs052200114.